The company — set to be acquired by Zimmer Biomet — said that, on July 26, the first-ever fully autonomous, saw-based robotic ...

Zimmer Biomet has scored an FDA clearance for a new component of its total knee replacement offering, aimed at patients who may be sensitive to certain metals or bone cement. The Persona SoluTion ...

By Elise Reuter - Medcity News on November 08, 2020 11:00 am ...

Compared to traditional partial knee replacements that use bone cement to secure the implant in place, a cementless approach allows patients' natural bone growth to secure the implant for better ...

WARSAW, Ind., and ZURICH, Nov. 18, 2024/ PRNewswire/-- Zimmer Biomet Holdings, Inc., a global medical technology leader, today received the CE Mark for its Persona ® Revision Knee System.

The U.S. Food and Drug Administration has authorized a "smart knee" implant developed by Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) and Canary Medical in Canada.

Persona OsseoTi is the latest addition to the clinically proven Persona Knee System, and features a new porous version of the Persona anatomic tibia with Zimmer Biomet's OsseoTi Porous Metal ...

Medtech firm Zimmer Biomet Holdings beat Wall Street estimates for first-quarter profit on Thursday, on the back of robust demand for its devices that are used in knee and hip reconstruction ...

Zimmer stumbled into a series of pitfalls in 2016-17, including integration issues, supply and inventory challenges, and quality concerns. The firm's efforts to turn itself around have been ...

Zimmer Biomet has secured the US Food and Drug Administration (FDA) 510(k) clearance for its total knee implant component, Persona SoluTion porous plasma spray (PPS) femur. It provides an ...

--Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare, today announced U.S. Food and Drug Administration 510 clearance of the ROSA ® Partial Knee System for robotically ...